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Burkholderia cenocepacia is an emerging opportunistic pathogen causing life-threatening infections in immunocompromised indi-
viduals and in patientswith cystic fibrosis, which are often difficult, if not impossible, to treat. Understanding the genetic basis of viru-
lence in this emerging pathogen is important for the development of novel treatment regimes. Generation of deletionmutations in
genes predicted to encode virulence determinants is fundamental to investigating themechanisms of pathogenesis.However, there is a
lack of appropriate selectable and counterselectablemarkers for use inB. cenocepacia, making its genetic manipulation problem-
atic. Here we describe a Gateway-compatible allelic exchange system based on the counterselectable pheS gene and the I-SceI
homing endonuclease. This system provides efficiency in cloning homology regions of target genes and allows the generation of
precise and unmarked gene deletions in B. cenocepacia. As a proof of concept, we demonstrate its utility by deleting the
Bcam1349 gene, encoding a cyclic di-GMP (c-di-GMP)-responsive regulator protein important for biofilm formation.
Burkholderia cenocepacia is a member of a group of closely re-lated Gram-negative bacteria referred to as the Burkholderia
cepacia complex (Bcc). The Bcc contains at least 18 different spe-
cies that thrive in diverse ecological niches, including clinical, in-
dustrial, and natural environments. These bacteria possess very
large genomes separated into multiple replicons and hence are
considered one of the most versatile groups of Gram-negative
bacteria (1, 2). Some Bcc species have biotechnological potential
for use in processes such as the enhancement of plant growth or
breakdown of pollutants, while others are opportunistic patho-
gens causing life-threatening infections in immunocompromised
individuals and in patients with cystic fibrosis (CF) (3). Although
all members of the Bcc have been isolated from CF patients, B.
cenocepacia accounts for themajority of these isolates, comprising
the most virulent and transmissible strains associated with a poor
clinical course and a high mortality rate (4). Therefore, research
on the virulence mechanisms of Bcc bacteria has focused largely
on B. cenocepacia.
The genomes of several B. cenocepacia strains have recently
been sequenced (5–7), enabling bioinformatics-based predictions
of virulence determinants in this pathogen. Although a number of
genes associated with virulence in B. cenocepacia have been iden-
tified (4, 8, 9) and tested in various infection models (10, 11), it
seems likely that the list of genes implicated in virulence is far from
complete andwill expandwith genetic tools becoming available to
manipulate B. cenocepacia strains. The deletion of genes poten-
tially associated with virulence is a powerful way to investigate
their function in bacterial physiology and pathogenesis. Most of
the virulence traits of B. cenocepacia, such as antibiotic resistance,
motility, biofilm formation, cell invasion, and intracellular sur-
vival, aremultifactorial, involvingmore than one gene; thus, mul-
tiple gene deletionsmay need to be generated in one strain to fully
assess the genetic basis of a particular virulence trait. This requires
an efficient method to generate gene deletions, which are prefer-
ably not marked with antibiotic resistance cassettes, as this would
prevent the ability to mutate more than a single gene in one par-
ticular strain and moreover may cause polar effects on adjacent
genes. During the past few years, a number of elegant systems have
been developed for the generation of unmarked gene deletions in
B. cenocepacia (12, 13) as well as in other Burkholderia species
(14–16). In these systems, regions of homology containing a mu-
tant allele of a target gene are cloned into a suicide vector. These
vectors are then transferred into the bacterial host by conjugation.
The integration of the plasmid into the chromosome by homolo-
gous recombination is selected by antibiotic resistance encoded by
a gene on the plasmid, leading to the formation of merodiploids,
which contain both the mutant and wild-type alleles of the target
gene. The resolution of merodiploids by the excision of the inte-
grated plasmid in a second homologous recombination event re-
sults in a population of cells of which a significant fraction con-
tains the desired gene deletion. The latter step usually requires
counterselection for the integrated plasmid since the second ho-
mologous recombination can be an exceptionally rare event.
Sucrose counterselection based on the sacB gene (15, 17) and
an engineered counterselectable marker based on the Burkhold-
eria pseudomallei pheS gene encoding the -subunit of phenylala-
nyl tRNA synthase (14) have been used in some Burkholderia
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species.However, they appear to be inappropriate and leaky coun-
terselectable markers for the generation of B. cenocepacia gene
deletions in our laboratory. Another way to stimulate the second
homologous recombination event and, consequently, the resolu-
tion of merodiploids is based on the yeast homing endonuclease
I-SceI, which recognizes a specific 18-bp sequence (12, 15). After
an allelic exchange vector carrying the I-SceI recognition site has
integrated into the chromosome, a replicative second plasmid
constitutively expressing the I-SceI enzyme is introduced into the
merodiploid bacteria. The I-SceI enzyme creates a double-
stranded DNA break at the I-SceI site within the integrated plas-
mid, which stimulates a second homologous recombination event
by the host’s DNA repair system. The excision of the integrated
plasmid results in a population of cells carrying either the wild-
type or the mutant allele, which can be identified by PCR and
partial sequencing.
Another major limitation of allelic exchange vectors for Burk-
holderia species is their dependence on restriction and ligation
enzymes for cloning. Restriction-free cloning based on Gateway
recombineering technology (18) is an alternative method that can
expedite the construction of gene replacement vectors containing
mutant alleles.
Here we present a Gateway-compatible allelic exchange system
for Burkholderia species that utilizes the I-SceI homing endonu-
clease and pheS-based counterselection. We further describe the
application of this system for generating in-frame and unmarked
gene deletions in B. cenocepacia H111. As a proof of concept, we
describe the deletion and complementation of theBcam1349 gene,
which is a regulator of biofilm formation in B. cenocepacia H111.
In addition, we also provide evidence that this system can be used
to make gene deletions in Burkholderia thailandensis, indicating
that it may be used in other Burkholderia species as well.
MATERIALS AND METHODS
Strains, plasmids, and growth conditions.The bacterial strains and plas-
mids used in this study are listed in Table 1. All B. cenocepacia and Esche-
richia coli strains were grown at 37°C. Luria broth (LB) medium was used
for overnight batch cultivation of all bacteria unless otherwise stated.
Solid media were prepared with 2% (wt/vol) agar. Eighty micrograms
tetracycline (Tet) ml1 (liquid medium), 120 g g Tet ml1 (solid me-
dium), 25 g gentamicin sulfate (Gm) ml1, 100 g kanamycin sulfate
(Km) ml1, and 100 g trimethoprim (Tp) ml1 were used for B. ceno-
cepacia strains, and 20 g Tet ml1, 10 g Gmml1, 50 g Kmml1, 50
g Tp ml1, 100 g ampicillin (Ap) ml1, and 25 g chloramphenicol
(Cm)ml1 were used for E. coli strains where appropriate. After conjugal
transfer of plasmids into B. cenocepacia, AB agar medium (19) supple-
mented with 10 mmol liter1 Na-citrate and appropriate antibiotics was
used to select for B. cenocepacia transconjugants. For self-curing of plas-
mid pDAI-SceI-pheS, 0.1% (wt/vol) p-chlorophenylalanine (cPhe) (DL-4-
chlorophenylalanine; Sigma-Aldrich) was autoclaved together with
B-salts solution and A-salts solution (19), and the carbon source of choice
was added thereafter.
Construction of Gateway-compatible allelic exchange vectors. The
attB1- and attB2-flanked Gateway donor site was amplified by PCR
from pDONR221 by using primers GWE-SceI-F (flanked by HindIII and
I-SceI restriction sites) and GWE-R (flanked by the XbaI site). The result-
ing 2.6-kb PCR product was digested with HindIII and XbaI and cloned
into HindIII/XbaI-digested plasmids pEX18Tp-pheS, pEX18Gm-pheS, and
pEX18Km-pheS(14), resulting intheallelicexchangevectorspDONRPEX18Tp-
SceI-pheS, pDONRPEX18Gm-SceI-pheS, and pDONRPEX18Km-SceI-
pheS, respectively (Fig. 1). The insertion of the Gateway donor site was
confirmed by restriction analysis and partial sequencing of the newly gen-
erated vectors. These vectors aremaintained in E. coli strain DB3.1, which
contains a gyrA462mutation (Invitrogen).
Construction of the I-SceI expression vector pDAI-SceI-pheS. To
construct pDAI-SceI-pheS (Fig. 1), an 1.2-kb fragment containing the
pheS genewas excised frompUC57-pheS (14) by restrictionwithXbaI and
TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid
Laboratory
identification no. Relevant characteristic(s)
Reference
or source
Strains
B. cenocepaciaH111 MF108 Clinical isolate from a cystic fibrosis patient 7
B. thailandensis CDC2721121 Clinical isolate from a patient with pleural infection 27
E. coli DH5 TTN322 Used for standard DNA manipulations Invitrogen
E. coli DB3.1 TTN312 Host for the Gateway-compatible gene replacement vectors Invitrogen
Plasmids
pBBR1MCS5 MF528 Broad-host-range cloning vector; Gmr 22
pBBR1MCS2 MF124 Broad-host-range cloning vector; Kmr 22
pMF564 MF564 Bcam1349 gene cloned into pBBR1MCS5 This study
pYedQ MF202 E. coli yedQ (yhcK) gene cloned into pRK404A 21
pYedQ2 MF217 yedQ gene cloned into the HindIII/BamHI site in pBBR1MCS5 This study
pRK600 TTN365 Helper plasmid in triparental conjugations; Cmr ori-ColE1 RK-mob RK-tra 28
pDONR221 TTN313 Source of Gateway donor site, Gateway donor vector; Kmr Invitrogen
pBBR1MCS-Km-pheS MF138 Engineered pheS cloned into pBBR1MCS2; Kmr 14
pEX18Tp-pheS MF322 Gene replacement vector based on pheS and Tpr 14
pEX18Gm-pheS MF320 Gene replacement vector based on pheS and Gmr 14
pEX18Km-pheS MF321 Gene replacement vector based on pheS and Kmr 14
pUC57-pheS MF130 Cloning vector containing engineered pheS; Apr 14
pDAI-SceI MF339 Cloning vector containing the I-SceI endonuclease; Tetr 12
pDONRPEX18Tp-SceI-pheS MF415 2.6-kb Gateway donor site cloned into the XbaI/HindIII site of pEX18Tp-pheS; Tpr This study
pDONRPEX18Gm-SceI-pheS MF356 2.6-kb Gateway donor site cloned into the XbaI/HindIII site of pEX18Gm-pheS; Gmr This study
pDONRPEX18Km-SceI-pheS MF414 2.6-kb Gateway donor site cloned into the XbaI/HindIII site of pEX18Km-pheS; Kmr This study
pENTRPEX18Tp-SceI-pheS-Bcam1349 MF455 Gene replacement vector containing the Bcam1349 deletion allele; Tpr This study
pENTRPEX18Tp-SceI-pheS-phzF MF450 Gene replacement vector containing the phzF deletion allele; Tpr This study
pDAI-SceI-pheS MF355 1.2-kb XbaI/SphI pheS fragment from pUC57-pheS cloned into the XbaI/SphI site of
pDAI-SceI
This study
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SphI and was ligated into XbaI/SphI-digested plasmid pDAI-SceI (12).
The presence of the insertion was verified by restriction analysis.
Construction of the gene replacement vector pENTRPEX18Tp-
SceI-pheS-Bcam1349. The upstream fragment of the Bcam1349 gene was
amplified by using primers Bcam1349-UpF-GWR and Bcam1349-UpR-
tail, and the downstream fragment of theBcam1349 genewas amplified by
using primers Bcam1349-DnF and Bcam1349-DnR-GWL (Table 2). Both
fragments were amplified by using Phusion high-fidelity DNA polymer-
ase (Thermo Scientific) according to the manufacturer’s instructions and
under the following thermal cycling conditions: 98°C for 2 min; 25 cycles of
98°C for 15 s, 64°C for 30 s, and 72°C for 1min; and a final extension step of
72°C for 7min. The PCR fragmentswere purified by using theWizard SV gel
and PCR Clean-Up system (Promega), and their concentrations were deter-
mined spectrophotometrically. The up- and downstream fragments were
fused together andamplifiedbyusingprimersGW-attB1andGW-attB2 (Ta-
ble 2) in splicing by overlap extension PCR (SOE PCR) (20) to generate the
Bcam1349 mutant allele as follows. Equal amounts (50 ng) of each up- and
downstream fragment and the other components of the PCRmixture except
FIG 1 Maps of the allelic exchange vectors and the I-SceI expression vector constructed in this study. (A to C) Gene replacement vectors, each containing a
different antibiotic resistance marker, were constructed by cloning the Gateway donor site into the XbaI/HindIII site of a set of pEX family vectors based on the
mutant pheS gene (14). attP1 and attP2, lambda recombination sites; CmR, chloramphenicol acetyltransferase; ccdB, gene encoding a gyrase-modifying enzyme;
dhfr, dihydrofolate reductase-encoding gene; aac1, Gm acetyltransferase-encoding gene; kanR, gene conferring resistance to kanamycin; pheS, mutant gene for
the-subunit of phenylalanyl tRNA synthase; PS12,B. pseudomallei rpsL gene promoter; I-SceI, I-SceI endonuclease recognition site; ColE1, origin of replication;
oriT, conjugal origin of transfer; M13-F and M13-R, primer binding sites for partial sequencing of the DNA sequence cloned into attP1-attP2 sites. (D)
pDAI-SceI-pheS was constructed by cloning the pheS gene into the XbaI/SphI site of plasmid pDAI-SceI (12). tetA and tetR, genes encoding the tetracycline-
specific efflux protein and repressor protein, respectively;mob, region facilitating conjugal transfer; I-SceI, I-SceI endonuclease; ori pBBR1, origin of replication;
rep, gene encoding the pBBR1 replication protein.
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primers GW-attB1 and GW-attB2 were mixed. PCR was carried out under
the following thermal cycling conditions: 98°C for 2min; 3 cycles of 98°C for
15 s, 64°C for 30 s, and 72°C for 1min; and a final extension step of 72°C for
1 min. The final extension step was paused at 30 s, primers GW-attB1 and
GW-attB2 were added, and thermal cycling was continued, with 27 cycles of
98°C for 15 s, 64°C for 30 s, and 72°C for 2 min and a final extension step of
72°C for7min.ThePCRproductwas thenpurifiedandverifiedby restriction
analysis.
A BP clonase reaction for the recombinational transfer of the mutant
allele into the allelic exchange vector pDONRPEX18Tp-SceI-pheS was
performed at 25°C overnight according to the Gateway cloning manual
(Invitrogen), using only one-half the recommended amount of BP clon-
ase II enzyme mix (Invitrogen). The BP clonase reaction product was
transferred into chemically competent E. coli DH5 cells. The transfor-
mants growing on LB agar plates containing 50g Tpml1 were screened
by colony PCR using primers GWE-SceI-F and GWE-R for insertion of
the deletion allele. A number of positive clones were streaked onto LB agar
plates containing 50 g Tp ml1 for purification, plasmid isolation, and
partial sequencing.
Construction of pYedQ2 and complementation plasmid pMF564.
Plasmid pYedQ2, which was used to elevate intracellular cyclic di-GMP
(c-di-GMP) levels, was constructed as follows. The yedQ expression cas-
settewas excised fromplasmid pYedQ (21) by restrictionwith BamHI and
HindIII and was inserted into the BamHI/HindIII-digested broad-host-
range cloning vector pBBR1MCS-5 (22). The presence of the insertion
was confirmed by restriction analysis.
Complementation plasmid pMF564 was constructed as follows. The
vector pBBR1MCS-5 was digested with SphI and blunt ended by T4 DNA
polymerase. The linearized vector was further digested with XbaI and
dephosphorylated with shrimp alkaline phosphatase. The SphI/XbaI di-
gestion removed the Plac promoter and the related regulatory sequences
from the plasmid. An 1.5-kb fragment containing the Bcam1349 gene
and its 0.7-kb upstream DNA sequence was PCR amplified by using
primers Bcam1349-RBS-F and Bcam1349-RBS-R, which were flanked by
SmaI and XbaI restriction sites, respectively. The PCR fragment was di-
gested with SmaI and XbaI and cloned into the previously linearized vec-
tor, yielding complementation plasmid pMF564. The presence of the in-
sertion was confirmed by restriction analysis.
Mutagenesis of B. cenocepacia H111. The gene replacement vector
pENTRPEXTp-SceI-pheS-Bcam1349 was introduced by conjugation into
B. cenocepacia via triparental mating, as described previously (23). The
cointegrants were selected for Tp resistance on AB-citrate agar plates con-
taining 100 g Tp ml1. Four Tp-resistant colonies were streaked onto
the same selective plates, and the growing colonies were screened for the
integration of the plasmid by colony PCR using primers Bcam1349-F and
Bcam1349-R (Table 2). A single positive merodiploid clone was trans-
formed with pDAI-SceI-pheS by triparental mating to stimulate the sec-
ond homologous recombination event and resolve the merodiploid state.
The transconjugants were screened for Tet resistance on AB-citrate agar
plates containing 120 g Tet ml1. Batches of 10 Tet-resistant colonies
were screened for the loss of the wild-type allele and the presence of the
desired gene deletion by colony PCR using primers Bcam1349-F and
Bcam1349-R. Two positive clones were purified by streaking and growing
the clones on an AB-citrate agar plate. Thereafter, a single colony for each
clone was picked and grown in 1ml AB-glucosemedium containing 0.1%
(wt/vol) cPhe at 37°C overnight in order to stimulate the loss of pDAI-
SceI-pheS via the counterselectable marker pheS on the plasmid. Tenfold
serial dilutions of the cultures grown overnight were plated onto LB agar
plates without any antibiotic, and 20 of the growing colonies of each clone
were patched onto LB agar plates with or without tetracycline by using a
sterile toothpick to screen for Tet sensitivity, which indicated the loss of
plasmid pDAI-SceI-pheS. A single positive colony for each clone was se-
lected and stored at80°C.
Phenotypic characterization of the B. cenocepacia Bcam1349 dele-
tion mutant. Colony morphology, pellicle formation, and flow cell bio-
film formation assays were performed as described previously (23).
RESULTS AND DISCUSSION
Features of the Gateway-compatible allelic exchange vectors.
The allelic exchange vectors pEX18Tp-pheS, pEX18Gm-pheS, and
pEX18Km-pheS, which contain different antibiotic resistance
markers, were first described by Barrett and colleagues (14). These
vectors are derivatives of a set of pEX family vectors (25), in which
the counterselectable marker gene sacB was replaced with a mu-
tant allele of the B. pseudomallei pheS gene. Here we modified
TABLE 2 Primers used in this study
Primer Sequence (5=–3=)
Gene specific
Bcam1349-UpF-GWLa TACAAAAAAGCAGGCTAACGGGGATTTCGCACGAT
Bcam1349-UpR-tailb GGACATCGACTGCATCGTCAAGCTCGAGTGAAGATGAAGCA
Bcam1349-DnF TGACGATGCAGTCGATGTCC
Bcam1349-DnR-GWRa TACAAGAAAGCTGGGTGAGATTGATCGCCGGCAT
Commonc
GW-attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCT
GW-attB2 GGGGACCACTTTGTACAAGAAAGCTGGGT
Amplification of the Gateway donor site
GWE-SceI-Fd TACTACAAGCTTTAGGGATAACAGGGTAATAGCATGGATGTTTTCCCAGT
GWE-Rd TACTACTCTAGATCAGAGATTTTGAGACACGGG
Othere
Bcam1349-F TACTACCCCGGGTAAATCGCTTATTCGGGCTG
Bcam1349-R TACTACTCTAGACATTCGTTCCACCGGACAT
Bcam1349-RBS-F TACTACTCTAGAATTGTCCGGAAATGGATTGGT
Bcam1349-RBS-R TACTACCCCGGGATTCGTTCCACCGGACAT
a Double-underlined sequences are common for all genes amplified and overlap the GW-attB primer sequences (29).
b The sequence in boldface type overlaps the gene-specific DnF primer.
c Sequences were obtained from reference 29.
d Restriction enzyme sites are single underlined, and the I-SceI endonuclease recognition site is in boldface type and double underlined.
e Restriction enzyme sites are underlined.
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these vectors for use as Gateway-compatible donor vectors to
clone regions of homology containing the deleted allele of a target
gene. This was carried out by cloning the Gateway donor site from
pDONR221 into the multicloning site of the above-mentioned
vectors. The 18-bp I-SceI recognition site was incorporated into
the vectors as a tail to the forward primer during PCR amplifica-
tion of the donor cassette. The resulting vectors (Fig. 1) contain
attP1 and attP2 sequences required for recombination-based
cloning and the ccdB gene as a counterselectable marker, which
kills gyrA host cells, such as E. coli DH5 cells, by inducing gy-
rase-mediated double-stranded DNA breaks, providing positive
selection for E. coli clones bearing plasmids with cloned inserts.
Additionally, the vectors contain the counterselectable pheS gene
(14) driven by the PS12 promoter of the B. pseudomallei rpsL gene
(26) and the I-SceI recognition site for downstream resolution of
merodiploids. Although the mutant pheS gene was shown to be
efficient in killing Burkholderia thailandensis cells in the presence
of cPhe when expressed as a single copy from the gene replace-
ment vector integrated on the chromosome (14), it was inefficient
in killing B. cenocepacia H111 cells, and the resolution of mero-
diploids was almost impossible when the cells were grown in the
presence of cPhe. Therefore, we incorporated the I-SceI site into
the gene replacement vectors for downstream resolution ofmero-
diploids. We preferred to keep the pheS gene on the gene replace-
ment vectors, as it can efficiently be utilized as a counterselectable
marker in strains such as B. thailandensis (14).
Featuresof the I-SceI expressionvectorpDAI-SceI-pheS.The
vector pDAI-SceI-pheS (Fig. 1), which constitutively expresses
the I-SceI endonuclease, is a derivative of the vector pDAI-SceI,
the features of which were previously described by Flannagan and
colleagues (12). Although the mutant pheS gene was not efficient
in killing B. cenocepacia cells in the presence of cPhe when ex-
pressed as a single copy on the chromosome, it effectively killed
almost all B. cenocepacia cells when expressed from the multicopy
plasmid pBBR1MCS-Km-pheS (14) (see Fig. S1 in the supplemen-
tal material), indicating that the mutant pheS gene has to be pres-
ent in multiple copies in the cells to provide effective counterse-
lection in B. cenocepacia. Based on this finding, we modified
pDAI-SceI by cloning the mutant B. pseudomallei pheS gene from
pUC57-pheS (14) into the multicloning site of pDAI-SceI to ex-
pedite self-curing of the plasmid. In the presence of 0.1% cPhe, the
mutant pheS gene enables efficient killing of B. cenocepacia cells
containing pDAI-SceI-pheS and curing of the B. cenocepacia dele-
tion mutants from the plasmid once they are obtained after the
resolution of merodiploids. In this way, the deletion mutants be-
come ready for subsequent rounds of mutagenesis.
FIG 2 Schematic diagram depicting the gene replacement procedure in B. cenocepacia H111 (A) and gel image (B). In step 1, the gene replacement vector
pENTRPEX18Tp-SceI-pheS-Bcam1349 (derivative of pDONRPEX18Tp-SceI-pheS) contains regions of homology flanking the Bcam1349 gene. The vector was
transferred into B. cenocepacia by conjugation and integrated into the chromosome by the first homologous recombination event, resulting in trimethoprim-
resistantmerodiploids, whichwere verified by colony PCR (B, lane 1). In step 2, themerodiploidwas transformedwith pDAI-SceI-pheS. The I-SceI endonuclease
expressed from the plasmid introduces a double-strandedDNA break at the I-SceI recognition site on the chromosome. In step 3, The DNA break stimulates the
second homologous recombination event through the host DNA repair system. Depending on the location of the second recombination event, the resolution of
themerodiploid state either generates the desired gene deletion (step 3A [A] and lane 3A [B]) or restores the wild-type allele (step 3B [A] and lane 3B [B]), which
is identified by colony PCR.
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Construction of the B. cenocepacia Bcam1349 deletion mu-
tant. Using the allelic exchange system described here, we have
successfully generated gene deletions in both B. cenocepaciaH111
and B. thailandensis (see the supplemental material). As a proof of
concept, we present a procedure that was used to delete the
Bcam1349 gene. This gene encodes a c-di-GMP-responsive CRP/
FNR superfamily transcription factor and regulates biofilm for-
mation in B. cenocepacia H111 (23, 24). We previously showed
that elevated intracellular levels of c-di-GMP promoted wrinkled-
colony formation on solid medium, robust pellicle formation at
the air-liquid interface of static liquid cultures, and increased bio-
film formation in flow cells. However, despite having high intra-
cellular c-di-GMP levels, a transposon insertion mutant of
Bcam1349 did not form wrinkled colonies, pellicles, or thick flow
cell biofilms (23).
We created the Bcam1349 mutant allele in two consecutive
PCR rounds using three primer pairs (Table 2). Two of these
primer pairs were gene specific, and one of themwas common and
can be used routinely. Gene-specific primers were designed to
amplify fragments ranging from 0.8 to 1 kb in size. The fragments
were chosen so that the gene-specific UpF-GWR primer is placed
within 10 to 100 bp after the gene start and the gene-specific
primer DnR-GWL is placed within 10 to 100 bp before the stop
codon. The gene-specific primers were compared to the B. ceno-
cepacia H111 genome to make sure that they would not fully an-
neal to unspecific regions in the genome. In the first PCR round,
the gene-specific primers were used to amplify up- and down-
stream homology regions of the target gene. We usually obtained
single major PCR products of the correct size, which were subse-
quently purified with a PCR cleanup kit and used in the second
PCR round. However, if there are multiple bands, the entire PCR
mixtures should be loaded onto an agarose gel, and fragments
with the correct size should be gel extracted. In the second PCR
round, equal amounts of up- and downstream PCR fragments
were fused together and amplifiedwith the commonprimersGW-
attB1 and GW-attB2 (Table 2), incorporating the attB1 and attB2
recombination sites at either end of the deletion allele. We usually
obtained a singlemajor PCR product of the correct size (2 kb) at
this step.
We recombined the Bcam1349 mutant allele into pDONRP
EX18Tp-SceI-pheS using BP clonase and transferred the entire BP
reaction product into E. coli DH5 cells. Tp-resistant transfor-
mants were selected, and the presence of the correct plasmid was
checked by colony PCR using primers GWE-SceI-F and GWE-R.
Alternatively, M13-F and M13-R primers can be used. Plasmids
were isolated from a number of positive clones, and the presence
of the deletion allele was verified by restriction analysis and partial
sequencing.
The resulting gene replacement vector, pENTRPEX18Tp-SceI-
pheS-Bcam1349, was transferred into B. cenocepacia by triparental
mating, giving rise to Tp-resistant merodiploids (Fig. 2A). The
integration of the nonreplicative vector into the chromosome can
normally be verified by colony PCR using gene-specific primers
UpF-GWR and DnR-GWL, often resulting in two PCR products
corresponding to the wild-type and deletion alleles (Fig. 2B).
However, we had to use another pair of primers, Bcam1349-F and
Bcam1349-R, to verify the integration of the vector, as the former
primer pair did not result in any PCR products. During the gen-
eration of deletion mutants of other genes, we also noticed that it
is not always possible to see a PCR product corresponding to the
wild-type allele, as its amplification may not be favored due to its
relatively large size compared to that of the deletion allele. A single
FIG 3 Phenotypic characterization of the Bcam1349 deletionmutant. Shown are colony morphology on AB-glucose agar medium (A) and pellicle formation in
static LB liquid culture (B) of the wild-type (WT) and Bcam1349 mutant strains carrying pYedQ2 and the wild-type strain carrying pBBR1MCS-5 (vector
control).
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merodiploid clone was selected and transformed with pDAI-SceI-
pheS by conjugation to stimulate the second homologous recom-
bination event via the generation of a double-strandedDNAbreak
by I-SceI endonuclease expressed from the plasmid. Depending
on the location of the second recombination event, the resolution
of the merodiploid state either restored the wild-type allele or
generated the desired gene deletion (Fig. 2A). Eight Tet-resistant
colonies were selected and verified for Bcam1349 deletion by col-
ony PCR. In our experience, at least one colony always contained
the desired gene deletion (Fig. 2B). Finally, the deletion mutant
was cured from plasmid pDAI-SceI-pheS by growing the mutant
in liquidmedium containing 0.1% cPhe, as described inMaterials
and Methods. The counterselection medium with cPhe should
not contain any competing phenylalanine for efficient counterse-
lection. We therefore prefer to use AB minimal medium supple-
mented with glucose as a carbon source. However, in the case of
deleting genes essential for growth in minimal medium, the mu-
tants can alternatively be cured from plasmid pDAI-SceI-pheS by
growing them in serial passages in richmediumwithout cPhe and
Tet, which is required for the maintenance of the plasmid.
Phenotypic characterization of the Bcam1349 deletion mu-
tant. We previously demonstrated that a transposon insertion
mutant of Bcam1349 did not form wrinkled colonies, robust pel-
licles, or thick flow cell biofilms despite having high intracellular
c-di-GMP levels (23). To characterize the Bcam1349 deletionmu-
tant obtained here, we first transformed it with plasmid pYedQ2,
which contains the E. coli diguanylate cyclase protein YedQ and
leads to elevated intracellular levels of c-di-GMP in B. cenocepacia
(23). Unlike the pYedQ2-containing wild type, the pYedQ2-con-
taining Bcam1349 mutant formed smooth colonies on AB agar
medium (Fig. 3A) and did not form robust pellicles in static liquid
culture (Fig. 3B). Furthermore, we tested the biofilm formation
ability of the Bcam1349 mutant in a flow cell biofilm system. In
accordance with the above-described results, the Bcam1349 mu-
tant wasmarkedly impaired in biofilm formation compared to the
wild-type strain (Fig. 4). To rule out the possibility that the ob-
served biofilm defect was due to a secondary mutation obtained
during the mutagenesis procedure, we genetically complemented
themutant strain with an intact copy of theBcam1349 gene and its
0.7-kb upstream DNA sequence on a replicative plasmid
(pMF564). After complementation of the mutant strain, the bio-
film formation ability was restored to wild-type levels (Fig. 4),
indicating that the biofilm defect was indeed a result of the
Bcam1349 deletion.
Conclusion. The Gateway-compatible allelic exchange system
described here takes advantage of bacteriophage lambda-based
site-specific recombination instead of the traditional cloning pro-
cedures based on restriction enzymes and ligase and provides flex-
ibility and efficiency. With proper primer design, the system al-
lows precise in-frame deletion of open reading frames without
generating truncated genes, reducing the risk of undesired polar
effects. Moreover, the unmarked nature of the deletion procedure
enables repetitive rounds of gene deletions in a single strain. We
believe that the allelic exchange system described here will be use-
ful in understanding the genetic basis of virulence in B. cenocepa-
cia and in systematic analyses of the functions of genes in the
physiology of this emerging pathogen and other Burkholderia spe-
cies withmedical relevance or potential biotechnological use. Fur-
thermore, this allelic exchange systemmay enable the engineering
of Burkholderia strains that retain their biotechnologically useful
functions but are attenuated for virulence.
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